ARTV Valuation

Artiva Biotherapeutics Inc (ARTV) has a current Price-to-Book (P/B) ratio of 0.63. Compared to its 3-year average P/B ratio of 0.50 , the current P/B ratio is approximately 24.95% higher. Relative to its 5-year average P/B ratio of 0.50, the current P/B ratio is about 24.95% higher. Artiva Biotherapeutics Inc (ARTV) has a Forward Free Cash Flow (FCF) yield of approximately -97.42%. Compared to its 3-year average FCF yield of -67.73%, the current FCF yield is approximately 43.84% lower. Relative to its 5-year average FCF yield of -67.73% , the current FCF yield is about 43.84% lower.